90 related articles for article (PubMed ID: 30902586)
1. Sensitive and selective detections of codon 12 and 13 KRAS mutations in a single tube using modified wild-type blocker.
Su N; Wei K; Zhao N; Wang L; Duan GJ; Ren XD; Qu XM; Huang Q
Clin Chim Acta; 2019 Jul; 494():123-131. PubMed ID: 30902586
[TBL] [Abstract][Full Text] [Related]
2. Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.
Huang JF; Zeng DZ; Duan GJ; Shi Y; Deng GH; Xia H; Xu HQ; Zhao N; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0145698. PubMed ID: 26701781
[TBL] [Abstract][Full Text] [Related]
3. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
[TBL] [Abstract][Full Text] [Related]
4. Wild‑type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS.
Peng J; Wei K; Zhao X; Yang K; Wang H; Zhang Y; Guo M; He J; Wu H; Li Y; Zhao N; Huang Q; Fu W
Mol Med Rep; 2017 Sep; 16(3):2726-2732. PubMed ID: 28677778
[TBL] [Abstract][Full Text] [Related]
5. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
[TBL] [Abstract][Full Text] [Related]
7. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
[TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of trace amounts of KRAS codon 12 mutations by a fast and novel one-step technique.
Xie F; Huang J; Qu S; Wu W; Jiang J; Wang H; Wang S; Liu Q; Zhang S; Xu L; Gao S; Zhang Y; Zhao J; Chen W
Clin Biochem; 2014 Nov; 47(16-17):237-42. PubMed ID: 25192863
[TBL] [Abstract][Full Text] [Related]
9. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening.
Pérez-Báez W; García-Latorre EA; Maldonado-Martínez HA; Coronado-Martínez I; Flores-García L; Taja-Chayeb L
Mol Cell Probes; 2017 Oct; 35():34-43. PubMed ID: 28627450
[TBL] [Abstract][Full Text] [Related]
10. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
[TBL] [Abstract][Full Text] [Related]
11. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib.
Smith JC; Brooks L; Hoff PM; McWalter G; Dearden S; Morgan SR; Wilson D; Robertson JD; Jürgensmeier JM
Eur J Cancer; 2013 Jul; 49(10):2424-32. PubMed ID: 23510802
[TBL] [Abstract][Full Text] [Related]
12. Rapid and sensitive detection of KRAS mutation after fast-COLD-PCR enrichment and high-resolution melting analysis.
Song C; Milbury CA; Li J; Liu P; Zhao M; Makrigiorgos GM
Diagn Mol Pathol; 2011 Jun; 20(2):81-9. PubMed ID: 21532494
[TBL] [Abstract][Full Text] [Related]
13. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
15. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Specificity of BRAF V600E Genotyping Using Wild-Type Blocker Coupled with Internal Competitive Reference in a Single Tube.
Peng J; Wei K; Yu S; Yang X; Zhao X; Liu Y; Zhu XY; Zhao N; Huang Q; Fu WL
Clin Lab; 2017 Oct; 63(10):1731-1740. PubMed ID: 29035465
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
Seekhuntod S; Thavarungkul P; Chaichanawongsaroj N
PLoS One; 2016; 11(1):e0147672. PubMed ID: 26812617
[TBL] [Abstract][Full Text] [Related]
19. LNA-based PCR clamping enrichment assay for the identification of KRAS mutations.
Efrati E; Elkin H; Peerless Y; Sabo E; Ben-Izhak O; Hershkovitz D
Cancer Biomark; 2010-2011; 8(2):89-94. PubMed ID: 21896996
[TBL] [Abstract][Full Text] [Related]
20. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]